News | Aalto Bio Regents

Kellie Meade

Aalto Bio Reagents Acquired by Biosynth Carbosynth to Strengthen its Global Life Science Enterprise

Urs Spitz (left) – CEO and President, Biosynth Carbosynth and Philip Noone (right) – CEO, Aalto Bio Reagents Dublin, 25 May 2022 - Aalto...

1,098 views0 comments

Kellie Meade

Aalto Bio Reagents Launches New Recombinant Mayaro Virus E2 Gylcoprotein, Domain A.

Dublin, Ireland – May 11th 2022 – Aalto Bio Reagents Ltd., a leading global developer of critical raw materials for the development of...

Rachel O'Reilly

Aalto Bio Reagents Announces 15 Pathogen Development Strategy to Solve the World's Future Diseases

Aalto Bio Reagents Ltd., a leading global developer of critical raw materials and reagents for the development of diagnostic tests, today...

Rory Quirkie

Aalto Bio Reagents Announces its New SARS-CoV-1 Spike Protein S1 Domain (Korean Outbreak Strain)

Dublin, Ireland – February 2nd 2022 – Aalto Bio Reagents ltd. a leading developer of critical raw materials and reagents for the...